These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 18180036)

  • 1. Alpha7 nicotinic acetylcholine receptor: a link between inflammation and neurodegeneration.
    Conejero-Goldberg C; Davies P; Ulloa L
    Neurosci Biobehav Rev; 2008; 32(4):693-706. PubMed ID: 18180036
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dissociating beta-amyloid from alpha 7 nicotinic acetylcholine receptor by a novel therapeutic agent, S 24795, normalizes alpha 7 nicotinic acetylcholine and NMDA receptor function in Alzheimer's disease brain.
    Wang HY; Stucky A; Liu J; Shen C; Trocme-Thibierge C; Morain P
    J Neurosci; 2009 Sep; 29(35):10961-73. PubMed ID: 19726654
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The alpha7 nicotinic acetylcholine receptor as a pharmacological target for inflammation.
    de Jonge WJ; Ulloa L
    Br J Pharmacol; 2007 Aug; 151(7):915-29. PubMed ID: 17502850
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting the α7 nicotinic acetylcholine receptor to prevent progressive dementia and improve cognition in adults with Down's syndrome.
    Deutsch SI; Burket JA; Benson AD
    Prog Neuropsychopharmacol Biol Psychiatry; 2014 Oct; 54():131-9. PubMed ID: 24865150
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nicotinic acetylcholine receptor α7 subunit: a novel therapeutic target for cardiovascular diseases.
    Liu C; Su D
    Front Med; 2012 Mar; 6(1):35-40. PubMed ID: 22460446
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting the alpha 7 nicotinic acetylcholine receptor to reduce amyloid accumulation in Alzheimer's disease pyramidal neurons.
    D'Andrea MR; Nagele RG
    Curr Pharm Des; 2006; 12(6):677-84. PubMed ID: 16472157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Localization of α7 nicotinic acetylcholine receptor immunoreactivity on GABAergic interneurons in layers I-III of the rat retrosplenial granular cortex.
    Murakami K; Ishikawa Y; Sato F
    Neuroscience; 2013 Nov; 252():443-59. PubMed ID: 23985568
    [TBL] [Abstract][Full Text] [Related]  

  • 8. α7 nicotinic acetylcholine receptors in Alzheimer's disease: neuroprotective, neurotrophic or both?
    Hernandez CM; Dineley KT
    Curr Drug Targets; 2012 May; 13(5):613-22. PubMed ID: 22300028
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alpha7 nicotinic acetylcholine receptor expression in Alzheimer's disease: receptor densities in brain regions of the APP(SWE) mouse model and in human peripheral blood lymphocytes.
    Jones IW; Westmacott A; Chan E; Jones RW; Dineley K; O'Neill MJ; Wonnacott S
    J Mol Neurosci; 2006; 30(1-2):83-4. PubMed ID: 17192639
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The p38 mitogen activated protein kinase regulates β-amyloid protein internalization through the α7 nicotinic acetylcholine receptor in mouse brain.
    Ma KG; Lv J; Yang WN; Chang KW; Hu XD; Shi LL; Zhai WY; Zong HF; Qian YH
    Brain Res Bull; 2018 Mar; 137():41-52. PubMed ID: 29128415
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alpha 7 nicotinic acetylcholine receptor and its effects on Alzheimer's disease.
    Ma KG; Qian YH
    Neuropeptides; 2019 Feb; 73():96-106. PubMed ID: 30579679
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mitogen-activated protein kinase signaling pathways are involved in regulating α7 nicotinic acetylcholine receptor-mediated amyloid-β uptake in SH-SY5Y cells.
    Yang WN; Ma KG; Chen XL; Shi LL; Bu G; Hu XD; Han H; Liu Y; Qian YH
    Neuroscience; 2014 Oct; 278():276-90. PubMed ID: 25168732
    [TBL] [Abstract][Full Text] [Related]  

  • 13. α7 Nicotinic receptor agonist enhances cognition in aged 3xTg-AD mice with robust plaques and tangles.
    Medeiros R; Castello NA; Cheng D; Kitazawa M; Baglietto-Vargas D; Green KN; Esbenshade TA; Bitner RS; Decker MW; LaFerla FM
    Am J Pathol; 2014 Feb; 184(2):520-9. PubMed ID: 24269557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuroprotective and Neurotoxic Implications of α7 Nicotinic Acetylcholine Receptor and Aβ Interaction: Therapeutic Options in Alzheimer's Disease.
    Farhat SM; Ahmed T
    Curr Drug Targets; 2017; 18(13):1537-1544. PubMed ID: 27719660
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The alpha7 nicotinic acetylcholine receptor on fibroblast-like synoviocytes and in synovial tissue from rheumatoid arthritis patients: a possible role for a key neurotransmitter in synovial inflammation.
    van Maanen MA; Stoof SP; van der Zanden EP; de Jonge WJ; Janssen RA; Fischer DF; Vandeghinste N; Brys R; Vervoordeldonk MJ; Tak PP
    Arthritis Rheum; 2009 May; 60(5):1272-81. PubMed ID: 19404936
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The N-butylcarbamate derivative of galantamine acts as an allosteric potentiating ligand on alpha7 nicotinic receptors in hippocampal neurons: clinical implications for treatment of Alzheimer's disease.
    Popa RV; Pereira EF; Lopes C; Maelicke A; Albuquerque EX
    J Mol Neurosci; 2006; 30(1-2):227-32. PubMed ID: 17192682
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Physiologic Functions and Therapeutic Applications of α7 Nicotinic Acetylcholine Receptor in Brain Disorders.
    Lee CH; Hung SY
    Pharmaceutics; 2022 Dec; 15(1):. PubMed ID: 36678660
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting the nicotinic alpha7 acetylcholine receptor to enhance cognition in disease.
    Wallace TL; Porter RH
    Biochem Pharmacol; 2011 Oct; 82(8):891-903. PubMed ID: 21741954
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Role of α7 Nicotinic Acetylcholine Receptors and α7-Specific Antibodies in Neuroinflammation Related to Alzheimer Disease.
    Skok M; Lykhmus O
    Curr Pharm Des; 2016; 22(14):2035-49. PubMed ID: 26818865
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The α7 nicotinic acetylcholine receptor: A mediator of pathogenesis and therapeutic target in autism spectrum disorders and Down syndrome.
    Deutsch SI; Burket JA; Urbano MR; Benson AD
    Biochem Pharmacol; 2015 Oct; 97(4):363-377. PubMed ID: 26074265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.